Tertiary Centre Study Highlights Low Inpatient Deintensification and Risks Associated with Adverse Outcomes in Frail People with Diabetes

Eka Melson*, Mohamed Fazil, Hnin Lwin, Anu Thomas, Ting Fong Yeo, Kevin Thottungal, HayMar Tun, Faseeha Aftab, Meri Davitadze, Alison Gallagher, Samuel Seidu, Kath Higgins

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction The community deintensification rates in older people with diabetes are low and hospital admission presents an opportunity for medication review. We audited the inpatient assessment and deintensification rate in people with diabetes and frailty. We also identified factors associated with adverse inpatient outcomes. Methods A retrospective review of electronic charts was conducted in all people with diabetes and clinical frailty score ≥6 who were discharged from the medical unit in 2022. Data on demographics, comorbidities and background glucose-lowering medications were collected. Results Six-hundred-and-sixty-five people with diabetes and moderate/severe frailty were included in our analysis. For people with no HbA1c in the last six months preceding admission, only 9.0% had it assessed during inpatient. Deintensification rates were 19.1%. Factors that were associated with adverse inpatient outcomes included inpatient hypoglycaemia, non-White ethnicity, and being overtreated (HbA1c
Original languageEnglish
Article number100029
JournalClinical Medicine
Early online date20 Feb 2024
DOIs
Publication statusE-pub ahead of print - 20 Feb 2024

Keywords

  • diabetes
  • frailty
  • quality improvment
  • inpatient hypoglycaemia

Fingerprint

Dive into the research topics of 'Tertiary Centre Study Highlights Low Inpatient Deintensification and Risks Associated with Adverse Outcomes in Frail People with Diabetes'. Together they form a unique fingerprint.

Cite this